Profil
Keith Barclay currently works at Caledonian Holdings Plc, as Investment Director from 2025.
Mr. Barclay also formerly worked at Elasmogen Ltd., as Director & Investor Director and Business Growth Fund Ltd, as Senior Investor from 2015 to 2024.
Mr. Barclay received his graduate degree from the University of Aberdeen.
Postes actifs de Keith Barclay
| Sociétés | Poste | Début |
|---|---|---|
| CALEDONIAN HOLDINGS PLC | Directeur en chef des Investissements | 01/08/2025 |
Anciens postes connus de Keith Barclay
| Sociétés | Poste | Fin |
|---|---|---|
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Invests in companies located in the United Kingdom and Ireland. The firm targets companies operating in the fields of acquisitions, internationalisation, technology, data and AI sectors. It provides financing for growth and early stage capital requirement with an investment size of GBP 3 - 30 million. It act as a minority investor and makes follow-on investments. | Private Equity Investor | 01/01/2024 |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Develops soloMER products for treatment of auto-immune mediated and inflammatory diseases | Directeur en chef des Investissements | - |
Formation de Keith Barclay
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Vela Technologies Plc
Vela Technologies Plc Financial ConglomeratesFinance Operates as an investment company | Finance |
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Invests in companies located in the United Kingdom and Ireland. The firm targets companies operating in the fields of acquisitions, internationalisation, technology, data and AI sectors. It provides financing for growth and early stage capital requirement with an investment size of GBP 3 - 30 million. It act as a minority investor and makes follow-on investments. | Finance |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Develops soloMER products for treatment of auto-immune mediated and inflammatory diseases | Health Technology |
















